LPM-6690176
- Generic Name
- LPM-6690176
First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Luye Pharma Group Ltd.
- Target Recruit Count
- 102
- Registration Number
- NCT06240546
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath